FOXP3 and Alzheimer disease: However, in later stages of the disease, systemic Foxp3+ Treg plays a negative role in the pathology of AD by altering the function of the choroid plexus and thereby reducing leukocyte recruitment to the CNS (Baruch et al., 2015).